151 related articles for article (PubMed ID: 8150783)
1. Growth factors and their receptors.
Tripathy D; Benz C
Hematol Oncol Clin North Am; 1994 Feb; 8(1):29-50. PubMed ID: 8150783
[TBL] [Abstract][Full Text] [Related]
2. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops.
de Jong JS; van Diest PJ; van der Valk P; Baak JP
J Pathol; 1998 Jan; 184(1):44-52. PubMed ID: 9582526
[TBL] [Abstract][Full Text] [Related]
3. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.
Turner BC; Zhang J; Gumbs AA; Maher MG; Kaplan L; Carter D; Glazer PM; Hurst HC; Haffty BG; Williams T
Cancer Res; 1998 Dec; 58(23):5466-72. PubMed ID: 9850080
[TBL] [Abstract][Full Text] [Related]
4. Implications of the new biology for therapy in breast cancer.
Sledge GW
Semin Oncol; 1996 Feb; 23(1 Suppl 2):76-81. PubMed ID: 8614850
[TBL] [Abstract][Full Text] [Related]
5. [Breast cancer and polypeptide growth factors].
Rømer J; Holst-Hansen C; Moser C; Brünner N
Nord Med; 1992; 107(2):49-52. PubMed ID: 1538961
[TBL] [Abstract][Full Text] [Related]
6. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis.
de Jong JS; van Diest PJ; van der Valk P; Baak JP
J Pathol; 1998 Jan; 184(1):53-7. PubMed ID: 9582527
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor: current understanding of its activation and modulation.
Osborne CK; Schiff R; Fuqua SA; Shou J
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4338s-4342s; discussion 4411s-4412s. PubMed ID: 11916222
[TBL] [Abstract][Full Text] [Related]
8. Growth factor requirements for normal and leukemic cells.
Minden M
Semin Hematol; 1995 Jul; 32(3):162-82. PubMed ID: 7570062
[TBL] [Abstract][Full Text] [Related]
9. ErbB receptors and their ligands in the breast.
Zahnow CA
Expert Rev Mol Med; 2006 Sep; 8(23):1-21. PubMed ID: 16984691
[TBL] [Abstract][Full Text] [Related]
10. Growth factors and acute renal failure.
Hirschberg R; Ding H
Semin Nephrol; 1998 Mar; 18(2):191-207. PubMed ID: 9541273
[TBL] [Abstract][Full Text] [Related]
11. Role of growth factors in pancreatic cancer.
Korc M
Surg Oncol Clin N Am; 1998 Jan; 7(1):25-41. PubMed ID: 9443985
[TBL] [Abstract][Full Text] [Related]
12. Growth factor signalling.
de Laat SW; Boonstra J; Defize LH; Kruijer W; van der Saag PT; Tertoolen LG; van Zoelen EJ; den Hertog J
Int J Dev Biol; 1999; 43(7):681-91. PubMed ID: 10668978
[TBL] [Abstract][Full Text] [Related]
13. The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.
Favoni RE; de Cupis A
Pharmacol Rev; 2000 Jun; 52(2):179-206. PubMed ID: 10835099
[TBL] [Abstract][Full Text] [Related]
14. Overview of the biologic markers of breast cancer.
Porter-Jordan K; Lippman ME
Hematol Oncol Clin North Am; 1994 Feb; 8(1):73-100. PubMed ID: 8150784
[TBL] [Abstract][Full Text] [Related]
15. Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.
Schiff R; Massarweh SA; Shou J; Bharwani L; Arpino G; Rimawi M; Osborne CK
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():10-20. PubMed ID: 16273359
[TBL] [Abstract][Full Text] [Related]
16. New approaches to reverse resistance to hormonal therapy in human breast cancer.
Weinberg OK; Marquez-Garban DC; Pietras RJ
Drug Resist Updat; 2005 Aug; 8(4):219-33. PubMed ID: 16054421
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response.
Schiff R; Massarweh S; Shou J; Osborne CK
Clin Cancer Res; 2003 Jan; 9(1 Pt 2):447S-54S. PubMed ID: 12538499
[TBL] [Abstract][Full Text] [Related]
18. New agents in development for breast cancer.
Gao XP; Liu F
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):68-74. PubMed ID: 17218855
[TBL] [Abstract][Full Text] [Related]
19. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
20. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
Clin Cancer Res; 2000 Nov; 6(11):4278-86. PubMed ID: 11106244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
